Found: 17
Select item for more details and to access through your institution.
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad069
- By:
- Publication type:
- Article
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35768-3
- By:
- Publication type:
- Article
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0057-5
- By:
- Publication type:
- Article
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 8, p. 1185, doi. 10.1086/529522
- By:
- Publication type:
- Article
Casting a wider net: Immunosurveillance by nonclassical MHC molecules.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 2, p. 1, doi. 10.1371/journal.ppat.1007567
- By:
- Publication type:
- Article
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00630-0
- By:
- Publication type:
- Article
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2029, doi. 10.3390/v15102029
- By:
- Publication type:
- Article
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 9, p. 1631, doi. 10.1093/cid/ciz219
- By:
- Publication type:
- Article
Adjunct Strategies for Tuberculosis vaccines: Modulating Key immune Cell Regulatory Mechanisms to Potentiate vaccination.
- Published in:
- Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00577
- By:
- Publication type:
- Article
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)–Supported Phase 2b Study Designs.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 928, doi. 10.1093/cid/ciae286
- By:
- Publication type:
- Article
Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 5, p. 965, doi. 10.1038/mt.2008.12
- By:
- Publication type:
- Article
Sooty mangabey ( Cercocebus torquatus atys) IGHG and IGHA genes.
- Published in:
- Immunogenetics, 2006, v. 58, n. 12, p. 955, doi. 10.1007/s00251-006-0152-z
- By:
- Publication type:
- Article
Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes.
- Published in:
- Immunogenetics, 2002, v. 54, n. 8, p. 556, doi. 10.1007/s00251-002-0505-1
- By:
- Publication type:
- Article
Baboon immunoglobulin variable region heavy chains: identification of genes homologous to members of the human IGHV1-IGHV7 subgroups.
- Published in:
- Immunogenetics, 2002, v. 53, n. 10/11, p. 815, doi. 10.1007/s00251-001-0418-4
- By:
- Publication type:
- Article
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 692, p. 1, doi. 10.1126/scitranslmed.ade9078
- By:
- Publication type:
- Article
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.
- Published in:
- Virology Journal, 2010, v. 7, p. 102, doi. 10.1186/1743-422X-7-102
- By:
- Publication type:
- Article